399 related articles for article (PubMed ID: 29953902)
1. Molecular targets of atypical antipsychotics: From mechanism of action to clinical differences.
Aringhieri S; Carli M; Kolachalam S; Verdesca V; Cini E; Rossi M; McCormick PJ; Corsini GU; Maggio R; Scarselli M
Pharmacol Ther; 2018 Dec; 192():20-41. PubMed ID: 29953902
[TBL] [Abstract][Full Text] [Related]
2. Equivalent occupancy of dopamine D1 and D2 receptors with clozapine: differentiation from other atypical antipsychotics.
Tauscher J; Hussain T; Agid O; Verhoeff NP; Wilson AA; Houle S; Remington G; Zipursky RB; Kapur S
Am J Psychiatry; 2004 Sep; 161(9):1620-5. PubMed ID: 15337652
[TBL] [Abstract][Full Text] [Related]
3. Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics?: A new hypothesis.
Kapur S; Seeman P
Am J Psychiatry; 2001 Mar; 158(3):360-9. PubMed ID: 11229973
[TBL] [Abstract][Full Text] [Related]
4. Atypical antipsychotic agents: a critical review.
Worrel JA; Marken PA; Beckman SE; Ruehter VL
Am J Health Syst Pharm; 2000 Feb; 57(3):238-55. PubMed ID: 10674777
[TBL] [Abstract][Full Text] [Related]
5. Atypical antipsychotics: mechanism of action.
Seeman P
Can J Psychiatry; 2002 Feb; 47(1):27-38. PubMed ID: 11873706
[TBL] [Abstract][Full Text] [Related]
6. Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia.
Kapur S; Zipursky RB; Remington G
Am J Psychiatry; 1999 Feb; 156(2):286-93. PubMed ID: 9989565
[TBL] [Abstract][Full Text] [Related]
7. Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding.
Schotte A; Janssen PF; Gommeren W; Luyten WH; Van Gompel P; Lesage AS; De Loore K; Leysen JE
Psychopharmacology (Berl); 1996 Mar; 124(1-2):57-73. PubMed ID: 8935801
[TBL] [Abstract][Full Text] [Related]
8. The importance of serotonin-dopamine interactions in the action of clozapine.
Meltzer HY
Br J Psychiatry Suppl; 1992 May; (17):22-9. PubMed ID: 1358125
[TBL] [Abstract][Full Text] [Related]
9. Amisulpride the 'atypical' atypical antipsychotic--comparison to haloperidol, risperidone and clozapine.
Natesan S; Reckless GE; Barlow KB; Nobrega JN; Kapur S
Schizophr Res; 2008 Oct; 105(1-3):224-35. PubMed ID: 18710798
[TBL] [Abstract][Full Text] [Related]
10. Discriminative stimulus properties of atypical and typical antipsychotic drugs: a review of preclinical studies.
Porter JH; Prus AJ
Psychopharmacology (Berl); 2009 Apr; 203(2):279-94. PubMed ID: 18795269
[TBL] [Abstract][Full Text] [Related]
11. In vivo receptor occupancy of NRA0045, a putative atypical antipsychotic, in rats.
Chaki S; Funakoshi T; Yoshikawa R; Okuyama S; Kumagai T; Nakazato A; Nagamine M; Tomisawa K
Neuropharmacology; 1999 Aug; 38(8):1185-94. PubMed ID: 10462131
[TBL] [Abstract][Full Text] [Related]
12. New insights into the biology of schizophrenia through the mechanism of action of clozapine.
Brunello N; Masotto C; Steardo L; Markstein R; Racagni G
Neuropsychopharmacology; 1995 Nov; 13(3):177-213. PubMed ID: 8602893
[TBL] [Abstract][Full Text] [Related]
13. Serotonin receptors: their key role in drugs to treat schizophrenia.
Meltzer HY; Li Z; Kaneda Y; Ichikawa J
Prog Neuropsychopharmacol Biol Psychiatry; 2003 Oct; 27(7):1159-72. PubMed ID: 14642974
[TBL] [Abstract][Full Text] [Related]
14. Interaction of antipsychotic drugs with neurotransmitter receptor sites in vitro and in vivo in relation to pharmacological and clinical effects: role of 5HT2 receptors.
Leysen JE; Janssen PM; Schotte A; Luyten WH; Megens AA
Psychopharmacology (Berl); 1993; 112(1 Suppl):S40-54. PubMed ID: 7530377
[TBL] [Abstract][Full Text] [Related]
15. Clozapine: new research on efficacy and mechanism of action.
Meltzer HY; Bastani B; Ramirez L; Matsubara S
Eur Arch Psychiatry Neurol Sci; 1989; 238(5-6):332-9. PubMed ID: 2569975
[TBL] [Abstract][Full Text] [Related]
16. [The atypical neuroleptic concept].
Azorin JM; Dassa D; Jalfre M
Encephale; 1992 Sep; 18 Spec No 3():453-7. PubMed ID: 1364079
[TBL] [Abstract][Full Text] [Related]
17. Clearing the Fog: A Review of Antipsychotics for Parkinson's-Related Hallucinations: A Focus on Pimavanserin, Quetiapine and Clozapine.
Abdul-Rahman T; Herrera-Calderón RE; Aderinto N; Kundu M; Wireko AA; Adebusoye FT; Ekerin O; Lawal L; Mykolaivna NI; Alexiou A; Almashjary MN; Perveen A; Ashraf GM
J Integr Neurosci; 2024 Apr; 23(4):80. PubMed ID: 38682215
[TBL] [Abstract][Full Text] [Related]
18. Novel antipsychotics in schizophrenia.
Mortimer AM
Expert Opin Investig Drugs; 2004 Apr; 13(4):315-29. PubMed ID: 15102583
[TBL] [Abstract][Full Text] [Related]
19. Novel targets for drugs in schizophrenia.
Stone JM; Pilowsky LS
CNS Neurol Disord Drug Targets; 2007 Aug; 6(4):265-72. PubMed ID: 17691983
[TBL] [Abstract][Full Text] [Related]
20. [Leponex, 10 years after -- a clinical review].
Llorca PM; Pere JJ
Encephale; 2004; 30(5):474-91. PubMed ID: 15627052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
